Abstract:Lingling Shan, 1 Yudie Li, 1 Yifan Ma, 2 Yang Yang, 1 Jing Wang, 1 Lei Peng, 1 Weiwei Wang, 1 Fang Zhao, 1 Wanrong Li, 1 Xiaoyuan Chen 3– 6 1 Institute of Pharmaceutical Biotechnology, School of Biology and Food Engineering, Suzhou University, Suzhou, People's Republic of China; 2 Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, People's Republic of China; 3 Departments of Diagnostic Radiology, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore, Singapore; 4 Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 5 Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; 6 Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A&astSTAR), Singapore, Singapore Correspondence: Xiaoyuan Chen; Lingling Shan, Email ; Background: While nanoplatform-based cancer theranostics have been researched and investigated for many years, enhancing antitumor efficacy and reducing toxic side effects is still an essential problem. Methods: We exploited nanoparticle coordination between ferric (Fe 2+ ) ions and telomerase-targeting hairpin DNA structures to encapsulate doxorubicin (DOX) and fabricated Fe 2+ -DNA@DOX nanoparticles (BDDF NPs). This work studied the NIR fluorescence imaging and pharmacokinetic studies targeting the ability and biodistribution of BDDF NPs. In vitro and vivo studies investigated the nano formula's toxicity, imaging, and synergistic therapeutic effects. Results: The enhanced permeability and retention (EPR) effect and tumor targeting resulted in prolonged blood circulation times and high tumor accumulation. Significantly, BDDF NPs could reduce DOX-mediated cardiac toxicity by improving the antioxidation ability of cardiomyocytes based on the different telomerase activities and iron dependency in normal and tumor cells. The synergistic treatment efficacy is enhanced through Fe 2+ -mediated ferroptosis and the β-catenin/p53 pathway and improved the tumor inhibition rate. Conclusion: Harpin DNA-based nanoplatforms demonstrated prolonged blood circulation, tumor drug accumulation via telomerase-targeting, and synergistic therapy to improve antitumor drug efficacy. Our work sheds new light on nanomaterials for future synergistic chemotherapy. Keywords: DNA nanomaterials, targeting, imaging, synergistic therapy Graphical An average of 13 nanomaterials have been approved for clinical antitumor therapy every five years since the mid-1990s. 1,2 This situation has extensively promoted the rapid development of nanomaterials. DNA nanostructures have the advantages of high programmability, addressability, modifiability, biocompatibility, and nontoxicity and have been widely used as drug delivery systems in treating malignant tumors. 3,4 However, multifunctional polymeric DNA nanodrug delivery systems have shortcomings in therapeutic applications, such as enzyme degradation, protein adsorption, and unclear metabolic pathways. 5,6 Therefore, numerous researchers have used combinations of DNA nanomaterials with other nanoparticles or polymer compounds, such as gold nanoparticles, 7 metal-organic frameworks (MOFs), 8 chitosan, 9 and polylysine, 10 to overcome the limitations of DNA nanomaterials. 11,12 As a result, the prepared DNA nanodrug delivery systems are polymers with complicated particle structures that are difficult to metabolize and have preparation and purification processes that are difficult to simplify. Since telomerase is specifically highly expressed in approximately 85% of tumor cells but poorly expressed in normal cells, it can target tumors. 13,14 Thus, telomerase-targeting DNA nanodrug delivery systems can be designed to load anticancer chemotherapy drugs and facilitate the recognition of tumor cells or tissues. A certain number of DNA fragments, such as 10–20 base DNA fragments, has recently been found to be rich in A/C base pairs and can form DNA nanostructures with ferric (Fe 2+ ) ions at high temperatures. 15,16 The preparation of these nanostructures requires a reaction at 95 °C for three hours. Reaction at high temperatures inevitably affects functional DNA activity and chemotherapy drug structure and fu -Abstract Truncated-

Exploring the robustness of DNA nanotubes framework for anticancer theranostics toward the 2D/3D clusters of hypopharyngeal respiratory tumor cells

Palindrome-mediated DNA nanotubes with cell-specific aptamers to improve targeted antitumor effects and reduce toxicity on non-small cell lung cancer

Nucleolin-Targeted DNA Nanotube for Precise Cancer Therapy Through Förster Resonance Energy Transfer-Indicated Telomerase Responsiveness.

DNA-Based Nanomedicine with Targeting and Enhancement of Therapeutic Efficacy of Breast Cancer Cells

Deformable Smart DNA Nanomachine for Synergistic Intracellular Cancer-Related miRNAs Imaging and Chemo-Gene Therapy of Drug-Resistant Tumors

Accurate Cancer Cell Identification and Microrna Silencing Induced Therapy Using Tailored DNA Tetrahedron Nanostructures

Synthesis of Ligand Functionalized ErbB-3 Targeted Novel DNA Nano-Threads Loaded with the Low Dose of Doxorubicin for Efficient In Vitro Evaluation of the Resistant Anti-Cancer Activity

Tetrahedral DNA Nanostructure-modified Gold Nanorod-based Anticancer Nanomaterials for Combined Photothermal Therapy and Chemotherapy.

Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy

Hairpin DNA-Based Nanomaterials for Tumor Targeting and Synergistic Therapy

Oxygen-producing and Ph-Responsive Targeted DNA Nanoflowers for Enhanced Chemo-Sonodynamic Therapy of Lung Cancer

A DNA-Based Nano Carrier for Efficient Cancer Therapy

Molecular Dynamics Study on DNA Nanotubes As Drug Delivery Vehicle for Anticancer Drugs

Hierarchical Multiplexing Nanodroplets for Imaging-Guided Cancer Radiotherapy Via DNA Damage Enhancement and Concomitant DNA Repair Prevention

A stable DNA Tetrahedra–AuNCs nanohybrid: On-site programmed disassembly for tumor imaging and combination therapy

"Sense-and-treat" DNA Nanodevice for Synergetic Destruction of Circulating Tumor Cells.

An Intelligent DNA Nanorobot with in Vitro Enhanced Protein Lysosomal Degradation of HER2.

Nucleic Acid-Mof Nanoparticle Conjugates for NIR/ATP-driven Synergetic Photo-Chemotherapy with Hypoxia Relief

DNA Origami–Anthraquinone Hybrid Nanostructures for In Vivo Quantitative Monitoring of the Progression of Tumor Hypoxia Affected by Chemotherapy

Triangle-toothed gear occlude-guided universal nanotechnology constructs 3D symmetric DNA polyhedra with high assembly efficiency for precision cancer therapy

Activatable Dual Cancer-Related RNA Imaging and Combined Gene-Chemotherapy through the Target-Induced Intracellular Disassembly of Functionalized DNA Tetrahedron